Adiponectin has anti-atherogenic and anti-inflammatory and insulin sensitizing properties and its plasma concentrations are decreased in obese individuals and type 2 diabetic mellitus (DM2) [9,47]. Here, ADIPOQ is linked to type 2 diabetes mellitus.